miR-155 gene: A typical multifunctional microRNA

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1792, Issue 6, 2009, Pages 497-505

  Faraoni, Isabella ^a   Antonetti, Francesca Romana ^b   Cardone, John ^a   Bonmassar, Enzo ^b,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c CNR   (Italy)

Author keywords

Cancer; Haematopoiesis; Immunity; Inflammation; Leukemia; Lymphoma; miR 155; miRNA

Indexed keywords

FIBROBLAST GROWTH FACTOR; MICRORNA;

ALZHEIMER DISEASE; B CELL LYMPHOMA; BIOGENESIS; CANCER DIAGNOSIS; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION; CHRONIC LYMPHATIC LEUKEMIA; DNA VIRUS; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC RISK; GENOMICS; HEMATOPOIESIS; HUMAN; IMMUNITY; INFLAMMATION; LEUKEMIA; MIR 155 GENE; NEOPLASM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOLID TUMOR; TUMOR GROWTH; VIRUS INFECTION;

ANIMALS; BASE SEQUENCE; CARDIOVASCULAR DISEASES; HEMATOPOIESIS; HUMANS; INFLAMMATION; MICRORNAS; NEOPLASMS;

ANIMALIA; DNA VIRUSES;

EID: 67349083526     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2009.02.013     Document Type: Review

References (81)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
2. Filipowicz W., Bhattacharyya S.N., and Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev., Genet. 9 (2008) 102-114
3. Singh S.K., Pal Bhadra M., Girschick H.J., and Bhadra U. MicroRNAs-micro in size but macro in function. FEBS J. 275 (2008) 4929-4944
4. Brameier M., and Wiuf C. Ab initio identification of human microRNAs based on structure motifs. BMC Bioinformatics 18 (2007) 478
5. Lagos-Quintana M., Rauhut R., Meyer J., Borkhardt A., and Tuschl T. New microRNAs from mouse and human. RNA 9 (2003) 175-179
6. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., and Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 432 (2004) 231-235
7. Kok K.H., Ng M.H., Ching Y.P., and Jin D.Y. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 282 (2007) 17649-17657
8. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., and Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436 (2005) 740-744
9. Diederichs S., and Haber D.A. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131 (2007) 1097-1108
10. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev., Mol. Cell Biol. 8 (2007) 23-36
11. Kertesz M., Iovino N., Unnerstall U., Gaul U., and Segal E. The role of site accessibility in microRNA target recognition. Nat. Genet. 39 (2007) 1278-1284
12. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., and Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 37 (2005) 495-500
13. Smalheiser N.R. Regulation of mammalian microRNA processing and function by cellular signaling and subcellular localization. Biochim. Biophys. Acta 1779 (2008) 678-681
14. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., and Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15524-15529
15. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., Shimizu M., Cimmino A., Zupo S., Dono M., Dell'Aquila M.L., Alder H., Rassenti L., Kipps T.J., Bullrich F., Negrini M., and Croce C.M. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11755-11760
16. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
17. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., and Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2257-2261
18. Lawrie C.H., Soneji S., Marafioti T., Cooper C.D., Palazzo S., Paterson J.C., Cattan H., Enver T., Mager R., Boultwood J., Wainscoat J.S., and Hatton C.S. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121 (2007) 1156-1161
19. Xu W., and Li J.Y. MicroRNA gene expression in malignant lymphoproliferative disorders. Chin. Med. J. (Engl.) 120 (2007) 996-999
20. Wang G., van der Walt J.M., Mayhew G., Li Y.J., Züchner S., Scott W.K., Martin E.R., and Vance J.M. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 82 (2008) 283-289
21. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., and Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28 (2008) 1213-1223
22. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., and Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12 (2002) 735-739
23. Masaki S., Ohtsuka R., Abe Y., Muta K., and Umemura T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem. Biophys. Res. Commun. 364 (2007) 509-514
24. 3rd Georgantas R.W., Hildreth R., Morisot S., Alder J., Liu C.G., Heimfeld S., Calin G.A., Croce C.M., and Civin C.I. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2750-2755
25. Taganov K.D., Boldin M.P., Chang K.J., and Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12481-12486
26. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., and Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 1604-1609
27. Stanczyk J., Pedrioli D.M., Brentano F., Sanchez-Pernaute O., Kolling C., Gay R.E., Detmar M., Gay S., and Kyburz D. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58 (2008) 1001-1009
28. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., and Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 316 (2007) 608-611
29. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., Schmidt-Supprian M., Rajewsky N., Yancopoulos G., Rao A., and Rajewsky K. Regulation of the germinal center response by microRNA-155. Science 316 (2007) 604-608
30. Vigorito E., Perks K.L., Abreu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., Das P.P., Miska E.A., Rodriguez A., Bradley A., Smith K.G., Rada C., Enright A.J., Toellner K.M., Maclennan I.C., and Turner M. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27 (2007) 847-859
31. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., and Papavasiliou F.N. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28 (2008) 621-629
32. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., Di Virgilio M., San-Martin B.R., Heidkamp G., Schwickert T.A., Eisenreich T., Rajewsky K., and Nussenzweig M.C. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28 (2008) 630-638
33. Tili E., Michaille J.J., Cimino A., Costinean S., Dumitru C.D., Adair B., Fabbri M., Alder H., Liu C.G., Calin G.A., and Croce C.M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179 (2007) 5082-5089
34. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
35. Ovcharenko D., Kelnar K., Johnson C., Leng N., and Brown D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res. 67 (2007) 10782-10788
36. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., Garcia S., Nowak J., Yeung M.L., Jeang K.T., Chaix A., Fazli L., Motoo Y., Wang Q., Rocchi P., Russo A., Gleave M., Dagorn J.C., Iovanna J.L., Carrier A., Pébusque M.J., and Dusetti N.J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 1617-16170
37. Kluiver J., Poppema S., de Jong D., Blokzijl T., Harms G., Jacobs S., Kroesen B.J., and van den Berg A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207 (2005) 243-249
38. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., and Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2632-3627
39. van den Berg A., Kroesen B.J., Kooistra K., de Jong D., Briggs J., Blokzijl T., Jacobs S., Kluiver J., Diepstra A., Maggio E., and Poppema S. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 39 (2004) 167-169
40. Metzler M., Wilda M., Busch K., Viehmann S., and Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39 (2004) 167-169
41. Rai D., Karanti S., Jung I., Dahia P.L., and Aguiar R.C. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet. Cytogenet. 181 (2008) 8-15
42. Kluiver J., Haralambieva E., de Jong D., Blokzijl T., Jacobs S., Kroesen B.J., Poppema S., and van den Berg A. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45 (2006) 147-153
43. Kluiver J., van den Berg A., de Jong D., Blokzijl T., Harms G., Bouwman E., Jacobs S., Poppema S., and Kroesen B.J. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 26 (2007) 3769-3776
44. Zhang T., Nie K., and Tam W. BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells. Leukemia 22 (2008) 1795-1797
45. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., and Croce C.M. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7024-7029
46. O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., Paquette R.L., and Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205 (2008) 585-594
47. Metcalf D., Dakic A., Mifsud S., Di Rago L., Wu L., and Nutt S. Inactivation of PU.1 in adult mice leads to the development of myeloid leukaemia. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1486-1491
48. Fulci V., Chiaretti S., Goldoni M., Azzalin G., Carucci N., Tavolaro S., Castellano L., Magrelli A., Citarella F., Messina M., Maggio R., Peragine N., Santangelo S., Mauro F.R., Landgraf P., Tuschl T., Weir D.B., Chien M., Russo J.J., Ju J., Sheridan R., Sander C., Zavolan M., Guarini A., Foà R., and Macino G. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukaemia. Blood 109 (2007) 4944-4951
49. Marton S., Garcia M.R., Robello C., Persson H., Trajtenberg F., Pritsch O., Rovira C., Naya H., Dighiero G., and Cayota A. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 22 (2008) 330-338
50. Nikiforova M.N., Tseng G.C., Steward D., Diorio D., and Nikiforov Y.E. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab 93 (2008) 1600-1608
51. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Ménard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., and Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005) 7065-7070
52. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X., and Shao J.Y. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 (2008) 2348-2360
53. Wang X., Tang S., Le S.Y., Lu R., Rader J.S., Meyers C., and Zheng Z.M. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3 (2008) e2557
54. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., Morgan D.L., Postier R.G., Brackett D.J., and Schmittgen T.D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120 (2007) 1046-1054
55. Szafranska A.E., Davison T.S., John J., Cannon T., Sipos B., Maghnouj A., Labourier E., and Hahn S.A. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26 (2007) 4442-4452
56. Jay C., Nemunaitis J., Chen P., Fulgham P., and Tong A.W. MiRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 26 (2007) 293-300
57. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., Croce C.M., and Harris C.C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
58. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., Calin G.A., Liu C.G., Franssila K., Suster S., Kloos R.T., Croce C.M., and de la Chapelle A. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19075-19080
59. Pallante P., Visone R., Ferracin M., Ferraro A., Berlingieri M.T., Troncone G., Chiappetta G., Liu C.G., Santoro M., Negrini M., Croce C.M., and Fusco A. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr. Relat. Cancer 13 (2006) 497-508
60. Visone R., Pallante P., Vecchione A., Cirombella R., Ferracin M., Ferraro A., Volinia S., Coluzzi S., Leone V., Borbone E., Liu C.G., Petrocca F., Troncone G., Calin G.A., Scarpa A., Colato C., Tallini G., Santoro M., Croce C.M., and Fusco A. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26 (2007) 7590-7595
61. Weber F., Teresi R.E., Broelsch C.E., Frilling A., and Eng C. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 91 (2006) 3584-3591
62. Martin M.M., Lee E.J., Buckenberger J.A., Schmittgen T.D., and Elton T.S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem. 281 (2006) 18277-18284
63. Martin M.M., Buckenberger J.A., Jiang J., Malana G.E., Nuovo G.J., Chotani M., Feldman D.S., Schmittgen T.D., and Elton T.S. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J. Biol. Chem. 282 (2007) 24262-24269
64. Sethupathy P., Borel C., Gagnebin M., Grant G.R., Deutsch S., Elton T.S., Hatzigeorgiou A.G., and Antonarakis S.E. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am. J. Hum. Genet. 81 (2007) 405-413
65. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., Braich R., Manoharan M., Soutschek J., Ohler U., and Cullen B.R. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450 (2007) 1096-1099
66. Skalsky R.L., Samols M.A., Plaisance K.B., Boss I.W., Riva A., Lopez M.C., Baker H.V., and Renne R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81 (2007) 12836-12845
67. Yin Q., McBride J., Fewell C., Lacey M., Wang X., Lin Z., Cameron J., and Flemington E.K. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82 (2008) 5295-5306
68. Mello C.C. Return to the RNAi world: rethinking gene expression and evolution. Cell Death Differ. 14 (2007) 2013-2020
69. Lagos-Quintana M., Rauhut R., Lendeckel W., and Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294 (2001) 853-858
70. Lau N.C., Lim L.P., Weinstein E.G., and Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 (2001) 858-862
71. Lee R.C., and Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294 (2001) 862-864
72. Voorhoeve P.M., and Agami R. Classifying microRNAs in cancer: the good, the bad and the ugly. Biochim. Biophys. Acta 1775 (2007) 274-282
73. Romania P., Lulli V., Pelosi E., Biffoni M., Peschle C., and Marziali G. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br. J. Haematol. 143 (2008) 570-580
74. Ceppi M., Pereira P.M., Dunand-Sauthier I., Barras E., Reith W., Santos M.A., and Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U. S. A (2009) published online before print February 4
75. Kong W., Yang H., He L., Zhao J., Coppolae3 D., Dalton W.S., and Cheng J.Q. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28 (2008) 6773-6784
76. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
77. Meister G., and Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 431 (2004) 343-349
78. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjärn M., Hansen H.F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E.M., and Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 452 (2008) 896-899
79. Tong A.W., and Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?. Cancer Gene Ther. 15 (2008) 341-355
80. Rossi L., Bonmassar E., and Faraoni I. Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol. Res. 56 (2007) 248-253
81. Blower P.E., Verducci J.S., Lin S., Zhou J., Chung J.H., Dai Z., Liu C.G., Reinhold W., Lorenzi P.L., Kaldjian E.P., Croce C.M., Weinstein J.N., and Sadee W. MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol. Cancer Ther. 6 (2007) 1483-1491